FORM 8-K


                      SECURITIES AND EXCHANGE COMMISSION

                            WASHINGTON, D.C. 20549



                ----------------------------------------------


                                CURRENT REPORT
                    Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934


                        Date of Report November 2, 2004
                       (Date of earliest event reported)


                          DENTSPLY INTERNATIONAL INC
                (Exact name of Company as specified in charter)



                     Delaware            0-16211        39-1434669
              (State of Incorporation) (Commission    (IRS Employer
                                       File Number)   Identification No.)




            221 West Philadelphia Street, York, Pennsylvania   17405
               (Address of principal executive offices)      (Zip Code)



                                (717) 845-7511
               (Company's telephone number including area code)












Item 5.02. - Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.

   The following information is furnished pursuant to Item 5.02, " Departure
of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers."

   On November 2, 2004, the Company appointed Mr. Eric K. Brandt to serve as a
member of the Company's Board of Directors with his initial term expiring at
the 2005 Annual Meeting of Shareholders. The announcement that was released
related to this appointment is attached hereto as Exhibit 99.1 and is hereby
incorporated by reference.


Item 9.01. - Financial Statements and Exhibits

(a)  Financial Statements - Not applicable.

(b)  Exhibits:

     99.1 The announcement related to the appointment of Mr. Eric K. Brandt to
          the Company's Board of Directors released on November 2, 2004 as
          referenced in Item 5.02.







SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                          DENTSPLY INTERNATIONAL INC
                                                    (Company)



                                          /s/ Bret W. Wise
                                              Bret W. Wise
                                              Senior Vice President and
                                              Chief Financial Officer

Date: November 5, 2004

George R. Rhodes                               FOR IMMEDIATE RELEASE
Corporate Communications
717-849-4273



                         DENTSPLY INTERNATIONAL NAMES
                          ERIC K. BRANDT AS DIRECTOR




York, PA - November 2, 2004 - DENTSPLY International Inc. (NASDAQ-XRAY)
today announced that Mr. Eric K. Brandt has been appointed to serve as a
member of the Board of Directors with his initial term expiring at the 2005
Annual Meeting of Shareholders. Mr. Brandt is the Executive Vice President,
Finance, Strategy and Corporate Development, Chief Financial Officer of
Allergan, Inc., an Irvine, California based global specialty pharmaceutical
company with 2003 revenues of approximately $1.8 billion.

Mr. Brandt joined Allergan in May 1999. In addition to his responsibilities
as Principal Financial Officer, Mr. Brandt served as President of the
Consumer Eye Care Business during 2001. Prior to joining Allergan, he was
Vice President and Partner at Boston Consulting Group, and a senior member
of the BCG Health Care practice. At BCG, Mr. Brandt was involved in high
level consulting engagements with top global pharmaceutical, managed care
and medical device companies, focusing on corporate finance, shareholder
value and post-merger integration.

Mr. Brandt earned his Bachelor of Science degree in chemical engineering
from the Massachusetts Institute of Technology and his Master of Business
Administration degree from the Harvard Business School. He currently serves
on the Board of Vertex Pharmaceuticals, Inc.

Mr. Gary Kunkle, DENTSPLY's Vice Chairman and Chief Executive Officer,
stated, "Our Company is very pleased to have someone of Mr. Brandt's
experience and talent joining our Board of Directors."


                                    (more)






                                      -2-

DENTSPLY designs, develops, manufactures and markets a broad range of
products for the dental market. The Company believes that it is the world's
leading manufacturer and distributor of dental prosthetics, precious metal
dental alloys, dental ceramics, endodontic instruments and materials,
prophylaxis paste, dental sealants, ultrasonic scalers, and crown and
bridge materials; the leading United States manufacturer and distributor of
dental handpieces, dental x-ray film holders, film mounts and bone
substitute/grafting materials; and a leading worldwide manufacturer or
distributor of dental injectible anesthetics, impression materials,
orthodontic appliances, dental cutting instruments and dental implants. The
Company distributes its dental products in over 120 countries under some of
the most well established brand names in the industry. DENTSPLY is
committed to the development of innovative, high quality, cost-effective
new products for the dental market.


###